In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer’s Disease
Drug Design, Development and Therapy · 2024
DOI: 10.2147/dddt.s432170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Shu-Tong Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China.
- Pharmaceutical College, Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
- School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, People's Republic of China.
- School of Pharmacy, Youjiang Medical University for Nationalities, Baise, Guangxi, People's Republic of China.
ORCID-Profile: Shu-Tong Huang, Guo-Hui Zhong, Chun-Li Tang, Lin Jing, Zhong-Bo Zhou, Neng Jiang
Zitieren
APA
Huang, S. T., Luo, J. C., Zhong, G. H., Teng, L. P., Yang, C. Y., Tang, C. L., Jing, L., Zhou, Z. B., Liu, J., & Jiang, N. (2024). In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer’s Disease. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s432170
Vancouver
Huang ST, Luo JC, Zhong GH, Teng LP, Yang CY, Tang CL, et al. In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer’s Disease. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s432170
BibTeX
@article{Huang2024,
author = {Huang, Shu-Tong and Luo, Jin-Chong and Zhong, Guo-Hui and Teng, Li-Ping and Yang, Cai-Yan and Tang, Chun-Li and Jing, Lin and Zhou, Zhong-Bo and Liu, Jing and Jiang, Neng},
title = {In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer’s Disease},
journal = {Drug Design, Development and Therapy},
year = {2024},
doi = {10.2147/dddt.s432170}
}
EUVIMED